<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33670299</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1796</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22041796</ELocationID><Abstract><AbstractText>Protein aggregates in affected motor neurons are a hallmark of amyotrophic lateral sclerosis (ALS), but the molecular pathways leading to their formation remain incompletely understood. Oxidative stress associated with age, the major risk factor in ALS, contributes to this neurodegeneration in ALS. We show that several genes coding for enzymes of the ubiquitin and small ubiquitin-related modifier (SUMO) pathways exhibit altered expression in motor neuronal cells exposed to oxidative stress, such as the CCNF gene mutated in ALS patients. Eleven of these genes were further studied in conditions combining oxidative stress and the expression of an ALS related mutant of the superoxide dismutase 1 (SOD1) gene. We observed a combined effect of these two environmental and genetic factors on the expression of genes, such as Uhrf2, Rbx1, Kdm2b, Ube2d2, Xaf1, and Senp1. Overall, we identified dysregulations in the expression of enzymes of the ubiquitin and SUMO pathways that may be of interest to better understand the pathophysiology of ALS and to protect motor neurons from oxidative stress and genetic alterations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dangoumau</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marouillat</LastName><ForeName>Sylviane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coelho</LastName><ForeName>Roxane</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0439-3545</Identifier><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wurmser</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brulard</LastName><ForeName>C&#xe9;line</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UTTIL, CHRU de Tours, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haouari</LastName><ForeName>Shanez</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laumonnier</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Neurologie, Centre de R&#xe9;f&#xe9;rence sur la SLA, CHRU de Tours, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andres</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Biochimie et de Biologie Mol&#xe9;culaire, CHRU de Tours, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasco</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Biochimie et de Biologie Mol&#xe9;culaire, CHRU de Tours, 37000 Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vourc'h</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UMR iBrain, Universit&#xe9; de Tours, Inserm, 37000 Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UTTIL, CHRU de Tours, 37000 Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Biochimie et de Biologie Mol&#xe9;culaire, CHRU de Tours, 37000 Tours, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025842">SUMO-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="Y">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025842" MajorTopicYN="N">SUMO-1 Protein</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">SUMO</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword></KeywordList><CoiStatement>The authors declare no actual or potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33670299</ArticleId><ArticleId IdType="pmc">PMC7918082</ArticleId><ArticleId IdType="doi">10.3390/ijms22041796</ArticleId><ArticleId IdType="pii">ijms22041796</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bendotti C., Marino M., Cheroni C., Fontana E., Crippa V., Poletti A., De Biasi S. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response. Prog. Neurobiol. 2012;97:101&#x2013;126. doi: 10.1016/j.pneurobio.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.10.001</ArticleId><ArticleId IdType="pubmed">22033150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.117</ArticleId><ArticleId IdType="pmc">PMC4351408</ArticleId><ArticleId IdType="pubmed">25766616</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangoumau A., Veyrat-Durebex C., Blasco H., Praline J., Corcia P., Andres C.R., Vourc&#x2019;H P. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Int. J. Neurosci. 2013;123:366&#x2013;374. doi: 10.3109/00207454.2012.761984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2012.761984</ArticleId><ArticleId IdType="pubmed">23289752</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurel C., Dangoumau A., Marouillat S., Brulard C., Chami A., Hergesheimer R., Corcia P., Blasco H., Andres C.R., Vourc&#x2019;H P. Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: A Link to Neurodegeneration. Mol. Neurobiol. 2018;55:6480&#x2013;6499. doi: 10.1007/s12035-017-0856-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0856-0</ArticleId><ArticleId IdType="pubmed">29322304</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T., Partridge L., Isaacs A.M. Ageing as a risk factor for ALS/FTD. Hum. Mol. Genet. 2017;26:R105&#x2013;R113. doi: 10.1093/hmg/ddx247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx247</ArticleId><ArticleId IdType="pubmed">28977441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuraszkiewicz B., Podsiad&#x142;y-Marczykowska T., Goszczy&#x144;ska H., Piotrkiewicz M. Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis? Front. Neurol. 2018;9:220. doi: 10.3389/fneur.2018.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00220</ArticleId><ArticleId IdType="pmc">PMC5897426</ArticleId><ArticleId IdType="pubmed">29681882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M., Brown R.H., Matson W., Smart R., Hayden D., O&#x2019;Donnell H., Flint Beal M., Cudkowicz M. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 2000;29:652&#x2013;658. doi: 10.1016/S0891-5849(00)00349-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00349-X</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T., Montezinho L., Mendes C., Firuzi O., Saso L., Oliveira P.J., Silva F.S.G. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxid. Med. Cell Longev. 2020;2020:1&#x2013;29. doi: 10.1155/2020/5021694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5021694</ArticleId><ArticleId IdType="pmc">PMC7683149</ArticleId><ArticleId IdType="pubmed">33274002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown R.H., Jr., Beal M.F. Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis. J. Neurochem. 2002;69:2064&#x2013;2074. doi: 10.1046/j.1471-4159.1997.69052064.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69052064.x</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., Kawaguchi M., Yamamoto T., Sasaki S., Kobayashi M. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res. 2001;917:97&#x2013;104. doi: 10.1016/S0006-8993(01)02926-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(01)02926-2</ArticleId><ArticleId IdType="pubmed">11602233</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P.C., Hentati A., Donaldson D.H., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., van den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Camu W., Brulard C., Marouillat S., Couratier P., Camdessanche J.P., Cintas P., Vershueren A., Soriani M.H., Desnuelle C., et al. Effect of Familial clustering in the genetic screening in 235 French ALS families. J. Neurol. Neurosurg. Psychiatry. 2021 doi: 10.1136/jnnp-2020-325064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325064</ArticleId><ArticleId IdType="pubmed">33408239</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleutherio E.C.A., Silva Magalh&#xe3;es R.S., de Ara&#xfa;jo Brasil A., Monteiro Neto J.R., de Holanda Paranhos L. SOD1, More than just an antioxidant. Arch. Biochem. Biophys. 2020;697:108701. doi: 10.1016/j.abb.2020.108701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2020.108701</ArticleId><ArticleId IdType="pubmed">33259795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;gan C., Vila M., Rosoklija G., Hays A.P., Przedborski S. Recruitment of the Mitochondrial-Dependent Apoptotic Pathway in Amyotrophic Lateral Sclerosis. J. Neurosci. 2001;21:6569&#x2013;6576. doi: 10.1523/JNEUROSCI.21-17-06569.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-17-06569.2001</ArticleId><ArticleId IdType="pmc">PMC6763092</ArticleId><ArticleId IdType="pubmed">11517246</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Althaus J.S., Ellerbrock B.R., Becker D.A., Gurney M.E. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 1998;44:763&#x2013;770. doi: 10.1002/ana.410440510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440510</ArticleId><ArticleId IdType="pubmed">9818932</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues. Neurobiol. Dis. 2001;8:933&#x2013;941. doi: 10.1006/nbdi.2001.0443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0443</ArticleId><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.-Y., Jeon G.S., Sung J. ALS-Linked Mutant SOD1 Associates with TIA-1 and Alters Stress Granule Dynamics. Neurochem. Res. 2020;45:2884&#x2013;2893. doi: 10.1007/s11064-020-03137-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03137-5</ArticleId><ArticleId IdType="pubmed">33025330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozumi I. Roles and therapeutic potential of metallothioneins in neurodegenerative diseases. Curr. Pharm. Biotechnol. 2013;14:408&#x2013;413. doi: 10.2174/1389201011314040004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389201011314040004</ArticleId><ArticleId IdType="pubmed">23590138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S.-I. Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis. Curr. Pharm. Des. 2018;23:5001&#x2013;5009. doi: 10.2174/1381612823666170622105513.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622105513</ArticleId><ArticleId IdType="pubmed">28641540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelle C., Vourc&#x2019;H P., Mignon L., Andres C.R. What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor? J. Mol. Evol. 2009;68:616&#x2013;628. doi: 10.1007/s00239-009-9225-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00239-009-9225-6</ArticleId><ArticleId IdType="pmc">PMC2691932</ArticleId><ArticleId IdType="pubmed">19452197</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Topp S.D., Yang S., Smith B., Fifita J.A., Warraich S.T., Zhang K.Y., Farrawell N., Vance C., Hu X., et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat. Commun. 2016;7:11253. doi: 10.1038/ncomms11253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrelet D., Perrin F.E., Liston P., Korneluk R.G., MacKenzie A., Ferrer-Alc&#xf3;n M., Kato A.C. Motoneuron Resistance to Apoptotic Cell Death In Vivo Correlates with the Ratio between X-Linked Inhibitor of Apoptosis Proteins (XIAPs) and Its Inhibitor, XIAP-Associated Factor 1. J. Neurosci. 2004;24:3777&#x2013;3785. doi: 10.1523/JNEUROSCI.0413-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0413-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729352</ArticleId><ArticleId IdType="pubmed">15084658</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata A., Nagashima Y., Matsumoto L., Suzuki T., Yamanaka T., Date H., Deoka K., Nukina N., Tsuji S. Intranuclear Degradation of Polyglutamine Aggregates by the Ubiquitin-Proteasome System. J. Biol. Chem. 2009;284:9796&#x2013;9803. doi: 10.1074/jbc.M809739200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809739200</ArticleId><ArticleId IdType="pmc">PMC2665101</ArticleId><ArticleId IdType="pubmed">19218238</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T., Ikeda D.D., Yamaguchi Y., Unoki M. NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape. FEBS Lett. 2012;586:1570&#x2013;1583. doi: 10.1016/j.febslet.2012.04.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2012.04.038</ArticleId><ArticleId IdType="pubmed">22673569</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Schmid B., Burbulla L.F., Sch&#xf6;ndorf D.C., Wagner L., Glatza M., H&#xf6;ing S., Hargus G., Heck S.A., Dhingra A., et al. Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression. Cell Stem Cell. 2013;12:354&#x2013;367. doi: 10.1016/j.stem.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.01.008</ArticleId><ArticleId IdType="pubmed">23472874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Hallstrom T.C. The Nuclear Protein UHRF2 Is a Direct Target of the Transcription Factor E2F1 in the Induction of Apoptosis. J. Biol. Chem. 2013;288:23833&#x2013;23843. doi: 10.1074/jbc.M112.447276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.447276</ArticleId><ArticleId IdType="pmc">PMC3745330</ArticleId><ArticleId IdType="pubmed">23833190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham H.D., Dahrouge S., Cashman N.R. Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing. NeuroToxicology. 1993;14:387&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">7909362</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier O., B&#xf6;hm J., Dahm M., Br&#xfc;ck S., Beyer C., Johann S. Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration. Neurochem. Int. 2013;62:1029&#x2013;1038. doi: 10.1016/j.neuint.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.03.008</ArticleId><ArticleId IdType="pubmed">23562846</ArticleId></ArticleIdList></Reference><Reference><Citation>Heck M.V., Azizov M., Stehning T., Walter M., Kedersha N., Auburger G. Dysregulated expression of lipid storage and membrane dynamics factors in Tia1 knockout mouse nervous tissue. Neurogenetics. 2014;15:135&#x2013;144. doi: 10.1007/s10048-014-0397-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0397-x</ArticleId><ArticleId IdType="pmc">PMC3994287</ArticleId><ArticleId IdType="pubmed">24659297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cook A., Kim J., Baranov S.V., Jiang J., Smith K., Cormier K., Bennett E., Browser R.P., Day A.L., et al. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;55:26&#x2013;35. doi: 10.1016/j.nbd.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.008</ArticleId><ArticleId IdType="pmc">PMC3652329</ArticleId><ArticleId IdType="pubmed">23537713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Okawa E., Watanabe S., Ono S. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1. Hum. Mol. Genet. 2014;23:1271&#x2013;1285. doi: 10.1093/hmg/ddt517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt517</ArticleId><ArticleId IdType="pubmed">24163136</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K., Kamitani T., Mori F., Kakita A., Takahashi H., Wakabayashi K. TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson&#x2019;s disease and dementia with Lewy bodies. Neurobiol. Dis. 2010;38:210&#x2013;218. doi: 10.1016/j.nbd.2010.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.01.007</ArticleId><ArticleId IdType="pmc">PMC2942959</ArticleId><ArticleId IdType="pubmed">20085810</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J., Wang Y., Luo Z., Chang L.-C., Yoo J.S., Yan H., Choi Y., Xie X., Deverman B.E., Gradinaru V., et al. TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice. Cell Rep. 2019;27:549&#x2013;560.e6. doi: 10.1016/j.celrep.2018.12.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.055</ArticleId><ArticleId IdType="pmc">PMC6485958</ArticleId><ArticleId IdType="pubmed">30970257</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkle C.C., McClain L.M., Valtschanoff J.G., Park C.S., Maglione C., Gupton S.L. A novel Netrin-1&#x2013;sensitive mechanism promotes local SNARE-mediated exocytosis during axon branching. J. Cell Biol. 2014;205:217&#x2013;232. doi: 10.1083/jcb.201311003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201311003</ArticleId><ArticleId IdType="pmc">PMC4003241</ArticleId><ArticleId IdType="pubmed">24778312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., Ng S.K., Diaz N., Burstein S., Morel L., Osgood A., Sider B., Higashimori H., Haydon P.G., Manfredi G., et al. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free. Radic. Biol. Med. 2009;47:1304&#x2013;1309. doi: 10.1016/j.freeradbiomed.2009.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.07.035</ArticleId><ArticleId IdType="pmc">PMC2763938</ArticleId><ArticleId IdType="pubmed">19666107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanno T., Tanaka K., Yanagisawa Y., Yasutake K., Hadano S., Yoshii F., Hirayama N., Ikeda J.-E. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2&#x2013;ARE pathway: Therapeutic implications for ALS. Free. Radic. Biol. Med. 2012;53:2028&#x2013;2042. doi: 10.1016/j.freeradbiomed.2012.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.09.010</ArticleId><ArticleId IdType="pubmed">23000247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain. 2005;128:1686&#x2013;1706. doi: 10.1093/brain/awh503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh503</ArticleId><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e A., LeCarpentier Y., Guillevin R., Vall&#xe9;e J.-N. Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington&#x2019;s disease. Rev. Neurosci. 2018;29:547&#x2013;555. doi: 10.1515/revneuro-2017-0075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0075</ArticleId><ArticleId IdType="pubmed">29303786</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C., C&#xe1;rdenas P., Osses N., Henr&#xed;quez J.P. Characterization of Wnt/&#x3b2;-catenin and BMP/Smad signaling pathways in an in vitro model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2013;7:239. doi: 10.3389/fncel.2013.00239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00239</ArticleId><ArticleId IdType="pmc">PMC3847560</ArticleId><ArticleId IdType="pubmed">24348333</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Nakagawa T., Morohoshi A., Nakagawa M., Ishida N., Suzuki N., Aoki M., Nakayama K. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity. Hum. Mol. Genet. 2019;28:3486&#x2013;3497. doi: 10.1093/hmg/ddz119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz119</ArticleId><ArticleId IdType="pubmed">31577344</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangoumau A., Verschueren A., Hammouche E., Papon M.-A., Blasco H., Cherpi-Antar C., Pouget J., Corcia P., Andres C.R., Vourc&#x2019;H P. A novel SOD1 mutation p.V31A identified with a slowly progressive form of amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:266.e1&#x2013;266.e4. doi: 10.1016/j.neurobiolaging.2013.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.07.012</ArticleId><ArticleId IdType="pubmed">23954173</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;gal L., Vanopdenbosch L., Tilkin P., Van den Bosch L., Thijs V., Sciot R., Robberecht W. The G93C mutation in superoxide dismutase 1: Clinicopathologic phenotype and prognosis. Arch. Neurol. 2006;63:262&#x2013;267. doi: 10.1001/archneur.63.2.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.2.262</ArticleId><ArticleId IdType="pubmed">16476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M., Yang Y., Deng H.-X., Hung W.-Y., Siddique T., Dellefave L., Gellera C., Andersen P.M. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology. 2009;72:1634&#x2013;1639. doi: 10.1212/01.wnl.0000343509.76828.2a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000343509.76828.2a</ArticleId><ArticleId IdType="pmc">PMC2683645</ArticleId><ArticleId IdType="pubmed">19176896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson M.R., Menzies F.M., Manning P., Eggett C.J., Figlewicz D.A., McNeil C.J., Shaw P.J. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2002;3:75&#x2013;85. doi: 10.1080/146608202760196048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760196048</ArticleId><ArticleId IdType="pubmed">12215229</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. p53 Is Abnormally Elevated and Active in the CNS of Patients with Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2000;7:613&#x2013;622. doi: 10.1006/nbdi.2000.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0314</ArticleId><ArticleId IdType="pubmed">11114260</ArticleId></ArticleIdList></Reference><Reference><Citation>Peuget S., Bonacci T., Soubeyran P., Iovanna J.L., Dusetti N. Oxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation. Cell Death Differ. 2014;21:1107&#x2013;1118. doi: 10.1038/cdd.2014.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.28</ArticleId><ArticleId IdType="pmc">PMC4207477</ArticleId><ArticleId IdType="pubmed">24608790</ArticleId></ArticleIdList></Reference><Reference><Citation>Saville M.K., Sparks A., Xirodimas D.P., Wardrop J., Stevenson L.F., Bourdon J.-C., Woods Y.L., Lane D.P. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. J. Biol. Chem. 2004;279:42169&#x2013;42181. doi: 10.1074/jbc.M403362200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403362200</ArticleId><ArticleId IdType="pubmed">15280377</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutahar N., Wierinckx A., Camdessanche J.P., Antoine J.-C., Reynaud E., Lassabliere F., Lachuer J., Borg J. Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis-linked mutant SOD1 cultured neurons. J. Neurosci. Res. 2011;89:1439&#x2013;1450. doi: 10.1002/jnr.22672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22672</ArticleId><ArticleId IdType="pubmed">21647936</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira G.P., Alves C.J., Chadi G. Early gene expression changes in spinal cord from SOD1G93A Amyotrophic Lateral Sclerosis animal model. Front. Cell. Neurosci. 2013;7:216. doi: 10.3389/fncel.2013.00216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00216</ArticleId><ArticleId IdType="pmc">PMC3831149</ArticleId><ArticleId IdType="pubmed">24302897</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A., Smith J.A., Gibson C., Varma A.K., Ray S.K., Banik N.L. Estrogen receptor agonists and estrogen attenuate TNF-&#x3b1;-induced apoptosis in VSC4.1 motoneurons. J. Endocrinol. 2010;208:171&#x2013;182. doi: 10.1677/JOE-10-0338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JOE-10-0338</ArticleId><ArticleId IdType="pmc">PMC3951893</ArticleId><ArticleId IdType="pubmed">21068071</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh Y., Chung K.C. UHRF2, a Ubiquitin E3 Ligase, Acts as a Small Ubiquitin-like Modifier E3 Ligase for Zinc Finger Protein 131*. J. Biol. Chem. 2013;288:9102&#x2013;9111. doi: 10.1074/jbc.M112.438234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.438234</ArticleId><ArticleId IdType="pmc">PMC3610983</ArticleId><ArticleId IdType="pubmed">23404503</ArticleId></ArticleIdList></Reference><Reference><Citation>Trappe R., Buddenberg P., Uedelhoven J., Gl&#xe4;ser B., Buck A., Engel W., Burfeind P. The murine BTB/POZ zinc finger gene Znf131: Predominant expression in the developing central nervous system, in adult brain, testis, and thymus. Biochem. Biophys. Res. Commun. 2002;296:319&#x2013;327. doi: 10.1016/S0006-291X(02)00850-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-291X(02)00850-1</ArticleId><ArticleId IdType="pubmed">12163020</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs S.B.R., Basak S., I Murray J., Pathak N., Attardi L.D. Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death Differ. 2007;14:1374&#x2013;1385. doi: 10.1038/sj.cdd.4402128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4402128</ArticleId><ArticleId IdType="pubmed">17464332</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44&#x2013;57. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom W.J., Russ C., Sapp P.C., McKenna-Yasek D., Hosler B.A., Andersen P.M., Brown R.H. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes. Neurosci. Lett. 2006;392:52&#x2013;57. doi: 10.1016/j.neulet.2005.08.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.08.058</ArticleId><ArticleId IdType="pubmed">16174551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>